Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Research & Development: 2019-2024

Historic Research & Development for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $140.6 million.

  • Mirum Pharmaceuticals' Research & Development rose 35.48% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.1 million, marking a year-over-year increase of 40.43%. This contributed to the annual value of $140.6 million for FY2024, which is 37.05% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Research & Development is $140.6 million, which was up 37.05% from $102.6 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Research & Development peaked at $140.6 million during FY2024, and registered a low of $81.6 million during FY2020.
  • Moreover, its 3-year median value for Research & Development was $106.8 million (2022), whereas its average is $116.7 million.
  • In the last 5 years, Mirum Pharmaceuticals' Research & Development spiked by 89.82% in 2020 and then declined by 18.71% in 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' Research & Development (Yearly) stood at $81.6 million in 2020, then skyrocketed by 61.05% to $131.4 million in 2021, then fell by 18.71% to $106.8 million in 2022, then fell by 3.96% to $102.6 million in 2023, then spiked by 37.05% to $140.6 million in 2024.